+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Filgotinib Tablets Market - Global Forecast 2026-2032- Product Image
Filgotinib Tablets Market - Global Forecast 2026-2032- Product Image
New

Filgotinib Tablets Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6116817
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The filgotinib tablets market is navigating a period of accelerated evolution, driven by shifting therapeutic approaches, regulatory developments, and new commercialization models in inflammatory disease management. Senior stakeholders are reevaluating investment, access, and operational priorities in response to this expanding landscape.

Market Snapshot: Filgotinib Tablets Market—Growth Trajectory and Market Drivers

The Filgotinib Tablets Market expanded from USD 2.04 billion in 2025 to USD 2.27 billion in 2026, maintaining robust growth at a CAGR of 14.39% and projected to reach USD 5.24 billion by 2032. This trajectory is shaped by increasing demand for JAK1 inhibitors in rheumatoid arthritis and ulcerative colitis, changing healthcare expectations around oral therapies, and ongoing shifts in global sourcing and distribution strategies.

Scope & Segmentation

This report provides comprehensive intelligence on the filgotinib tablets market, contextualizing its strategic landscape across the following dimensions:

  • Indications: Rheumatoid arthritis, ulcerative colitis, and associated subgroups stratified by treatment response and disease state.
  • Dosage Strengths: 50 mg and 100 mg tablets, each with specific adherence and dosing challenges.
  • Distribution Channels: Hospital pharmacies (public/private), retail pharmacies (chain/independent), online/direct-to-patient platforms, and third-party e-retailers.
  • End Users: Home healthcare, hospitals (inpatient/outpatient), and specialty clinics (rheumatology, gastroenterology).
  • Treatment Lines: First-line (treatment-naïve) and second-line strategies (prior biologic or conventional DMARD exposure).
  • Regions: Americas, Europe Middle East and Africa, Asia-Pacific; each with unique payer, regulatory, and distribution dynamics.

Key Takeaways for Senior Decision-Makers

  • Filgotinib tablets’ mode of action and oral administration enhance appeal in patient-centric inflammatory disease care, especially as real-world evidence continues to guide prescribing practices.
  • Stakeholder engagement from clinical development through market access is essential; organizations must collaborate across medical, regulatory, commercial, and supply chain teams for effective entry and lifecycle management.
  • Market access strategies increasingly depend on digital distribution channels, patient support initiatives, and integrated telehealth services to drive adherence and expand outreach.
  • Payer strategies are evolving, with greater scrutiny on value demonstration, implementation of step therapy, and demand for differentiated health economic outcomes.
  • Segmentation by dosage, indication, and user setting enables precision positioning—ensuring relevant messaging, product support, and commercialization tactics for distinct cohorts.
  • Adapting to regional regulatory and channel maturity is vital, as access frameworks differ widely across geographies and often require country- or even state-level engagement.

Tariff Impact: Strategic Considerations in the United States

The introduction and adjustment of United States tariffs in 2025 are influencing filgotinib tablets’ supply chain, procurement, and pricing strategies. Tariff-driven changes are resulting in higher landed costs and tighter margins, driving companies to prioritize supplier diversification and risk mitigation through dual sourcing or nearshoring. These developments are also prompting manufacturers and distributors to reassess contracting, pricing, and inventory practices to sustain commercial viability and maintain uninterrupted access for stakeholders across the ecosystem.

Methodology & Data Sources

This report applies a mixed-methods approach, combining insights from qualitative interviews with clinicians, payers, procurement leaders, and channel executives, alongside thorough reviews of regulatory filings and published literature. Scenario analysis and thematic synthesis strengthen the actionable recommendations presented, while data triangulation ensures alignment across primary and secondary sources for strategic robustness.

SEO-Focused Insights: Filgotinib Tablets Market and B2B Commercial Strategies

Primary keyword: Filgotinib tablets market

The filgotinib tablets market is characterized by a complex clinical and commercial environment. Technology integration, especially for digital engagement, is enabling omnichannel distribution and patient support solutions, improving adherence and expanding channel reach. Stakeholders are increasingly aware of segment and region-specific opportunities, influencing investment in evidence generation and supply chain resilience.

Why This Report Matters

  • Enables senior decision-makers to anticipate and adapt to dynamic clinical, regulatory, and supply chain forces shaping commercial outcomes in the JAK1 oral therapy segment.
  • Provides actionable segmentation and channel insights for targeting high-value cohorts and maximizing resource allocation.
  • Supports cross-functional alignment with transparent methodology and grounded, operationally relevant recommendations.

Conclusion

Realizing the full potential of filgotinib tablets calls for coordinated action across evidence generation, commercial planning, and resilient supply. Organizations that align clinical and market strategies can navigate access complexities and sustain long-term adoption in this evolving market.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Surge in real-world data studies evaluating filgotinib safety and efficacy in diverse RA populations
5.2. Intensifying pricing negotiations with European payers amid biosimilar JAK inhibitor competition
5.3. Expansion of filgotinib clinical trials into ulcerative colitis and Crohn’s disease for label extension
5.4. Impact of recent EMA and FDA safety warnings on filgotinib prescribing patterns in elderly patients
5.5. Strategic partnerships between Gilead and regional manufacturers to improve filgotinib supply chain resilience
5.6. Implementation of patient support programs and digital adherence tools to boost filgotinib compliance
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Filgotinib Tablets Market, by Indication
8.1. Introduction
8.2. Rheumatoid Arthritis
8.2.1. BDMARDs Inadequate Responders
8.2.2. CsDMARDs Inadequate Responders
8.3. Ulcerative Colitis
8.3.1. Steroid-Dependent Patients
8.3.2. Steroid-Refractory Patients
9. Filgotinib Tablets Market, by Dosage Strength
9.1. Introduction
9.2. 100 Mg Tablet
9.3. 50 Mg Tablet
10. Filgotinib Tablets Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.2.1. Government Hospitals
10.2.2. Private Hospitals
10.3. Online Pharmacies
10.3.1. Direct To Patient Platforms
10.3.2. Third Party E Retailers
10.4. Retail Pharmacies
10.4.1. Chain Pharmacies
10.4.2. Independent Pharmacies
11. Filgotinib Tablets Market, by End User
11.1. Introduction
11.2. Home Healthcare
11.2.1. Home Health Nurse Administration
11.2.2. Self Administration
11.3. Hospitals
11.3.1. Inpatient Services
11.3.2. Outpatient Services
11.4. Specialty Clinics
11.4.1. Gastroenterology Clinics
11.4.2. Rheumatology Clinics
12. Filgotinib Tablets Market, by Treatment Line
12.1. Introduction
12.2. First Line Treatment
12.2.1. Treatment Naïve Patients
12.3. Second Line Treatment
12.3.1. BDMARDs Experienced
12.3.2. CsDMARDs Experienced
13. Americas Filgotinib Tablets Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Filgotinib Tablets Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Filgotinib Tablets Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Gilead Sciences, Inc.
16.3.2. Galapagos NV
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. FILGOTINIB TABLETS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL FILGOTINIB TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC FILGOTINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC FILGOTINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. FILGOTINIB TABLETS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. FILGOTINIB TABLETS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. FILGOTINIB TABLETS MARKET: RESEARCHAI
FIGURE 26. FILGOTINIB TABLETS MARKET: RESEARCHSTATISTICS
FIGURE 27. FILGOTINIB TABLETS MARKET: RESEARCHCONTACTS
FIGURE 28. FILGOTINIB TABLETS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. FILGOTINIB TABLETS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FILGOTINIB TABLETS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL FILGOTINIB TABLETS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY BDMARDS INADEQUATE RESPONDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY BDMARDS INADEQUATE RESPONDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY CSDMARDS INADEQUATE RESPONDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY CSDMARDS INADEQUATE RESPONDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY STEROID-DEPENDENT PATIENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY STEROID-DEPENDENT PATIENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY STEROID-REFRACTORY PATIENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY STEROID-REFRACTORY PATIENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY 100 MG TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY 100 MG TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY 50 MG TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY 50 MG TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY DIRECT TO PATIENT PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY DIRECT TO PATIENT PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY THIRD PARTY E RETAILERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY THIRD PARTY E RETAILERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTH NURSE ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTH NURSE ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY INPATIENT SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY INPATIENT SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY OUTPATIENT SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY OUTPATIENT SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY GASTROENTEROLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY GASTROENTEROLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT NAÏVE PATIENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT NAÏVE PATIENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY BDMARDS EXPERIENCED, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY BDMARDS EXPERIENCED, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY CSDMARDS EXPERIENCED, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY CSDMARDS EXPERIENCED, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS FILGOTINIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES FILGOTINIB TABLETS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 165. CANADA FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 166. CANADA FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 167. CANADA FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 168. CANADA FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 169. CANADA FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 170. CANADA FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 171. CANADA FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 172. CANADA FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 173. CANADA FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. CANADA FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. CANADA FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 176. CANADA FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 177. CANADA FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 178. CANADA FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 179. CANADA FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 180. CANADA FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 181. CANADA FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. CANADA FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. CANADA FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 184. CANADA FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 185. CANADA FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 186. CANADA FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 187. CANADA FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 188. CANADA FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 189. CANADA FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 190. CANADA FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 191. CANADA FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, 2018-2024 (USD MILLION)
TABLE 192. CANADA FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, 2025-2030 (USD MILLION)
TABLE 193. CANADA FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, 2018-2024 (USD MILLION)
TABLE 194. CANADA FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, 2025-2030 (USD MILLION)
TABLE 195. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 196. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 197. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 199. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 200. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 201. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 202. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 203. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 206. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 207. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 208. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 209. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 210. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 211. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 214. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 215. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 216. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 217. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 218. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 220. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 221. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, 2018-2024 (USD MILLION)
TABLE 222. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, 2025-2030 (USD MILLION)
TABLE 223. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, 2018-2024 (USD MILLION)
TABLE 224. MEXICO FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY FIRST LINE TREATMENT, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY SECOND LINE TREATMENT, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA FILGOTINIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 318. UNITED KINGDOM FILGOTINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2024 (USD MILLION)
TABLE 320. UNITED KINGDOM FILGOTINIB TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2025-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 322. UNITED KINGDOM FILGOTINIB TABLETS MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 324. UNITED KINGDOM FILGOTINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. UNITED KINGDOM FILGOTINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILL

Companies Mentioned

  • Apino Pharma Co., Ltd.
  • Aurobindo Pharma Ltd.
  • Beijing Sjar Technology Development Co., Ltd.
  • Biocon Limited
  • Cadila Healthcare Limited
  • Cambrex Corporation
  • Cipla Limited
  • Divi's Laboratories Limited
  • Dr. Reddy's Laboratories Ltd.
  • Galapagos NV
  • Gilead Sciences, Inc.
  • Glenmark Pharmaceuticals Limited
  • Hetero Drugs Limited
  • Hutchison MediPharma International Limited
  • Lupin Limited
  • Metrochem API Private Limited
  • SETV Global Co., Ltd.
  • Shandong Perfect Biotechnology Co., Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Limited

Table Information

Report AttributeDetails
No. of Pages182
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.27 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.24 Billion
Compound Annual Growth Rate14.3%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Tofacitinib Citrate Extended-Release Tablets Market - Global Forecast 2025-2030 - Product Image

Tofacitinib Citrate Extended-Release Tablets Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Mizoribine Tablets Market - Global Forecast 2025-2030 - Product Image

Mizoribine Tablets Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Imipramine Hydrochloride Tablet Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application - Product Image

Imipramine Hydrochloride Tablet Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

  • Report
  • 74 Pages
  • Global
From
Mercaptopurine Tablet Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Mercaptopurine Tablet Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Sotorasib Tablets Market Report 2025 - Product Image

Sotorasib Tablets Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.